In Toronto last night, at a gala celebration at the Ripley’s Aquarium of Canada, Cantech Letter Editor Nick Waddell presented the 7th Annual Cantech Letter Awards to a crowd of several hundred tech enthusiasts.
The nominees included a mix of new and familiar names, including TIO Networks and its CEO Hamed Shahbazi. Though TIO was thwarted in its bid for a third consecutive TSXV Canadian Tech Stock of the Year Award, Shahbazi himself completed the hat-trick as TSXV Tech Executive of the Year.
The Cantech Letter Awards recognize excellence in Canada’s innovation sectors. They are selected by an anonymous panel of more than 40 sell-side analysts from dozens of Canadian investment banks.
Here is a complete list of nominees and finalists for the 2016 Cantech Letter Awards…
2016 CANTECH LETTER AWARDS FINALISTS
CANADIAN TECH STOCK OF THE YEAR (TSX)
• Intrinsyc Technologies Corp
• OpenText
• Shopify
Winner: Shopify
CANADIAN TECH STOCK EXECUTIVE OF THE YEAR (TSX)
• Mark Barrenechea, OpenText
• Tobias Lutke, Shopify
• Elliot Noss, Tucows
Winner: Mark Barrenechea, OpenText
CANADIAN TECH STOCK OF THE YEAR (TSXV)
• AcuityAds
• Symbility Solutions
• Tio Networks
Winner: AcuityAds
CANADIAN TECH STOCK EXECUTIVE OF THE YEAR (TSXV)
• Mike Checkley, QHR
• Tal Hayek, AcuityAds
• Hamed Shahbazi, TIO Networks
Winner: Hamed Shahbazi, TIO Networks
CANADIAN LIFE SCIENCES STOCK OF THE YEAR
• Knight Therapeutics
• Theratechnologies
• TSO3
Winner: Theratechnologies
Roth Capital Markets analyst Suji Desilva raised his price target for Ambarella (Ambarella Stock Quote, Chart, News, Analysts, Financials NASDAQ:AMBA)… [Read More]
Darren Sissons, partner and portfolio manager at Campbell, Lee & Ross Investment Management, told BNN Bloomberg’s Market Call on Aug.… [Read More]
Beacon Securities analyst Doug Cooper maintained a “Buy” rating and $5.00 target for NTG Clarity Networks (NTG Clarity Networks Stock… [Read More]
Research Capital analyst Andre Uddin lowered his target price for NervGen Pharma (NervGen Pharma Stock Quote, Chart, News, Analysts, Financials… [Read More]
Research Capital analyst Andre Uddin maintained a “Speculative buy” rating and C$0.70 target price on Theralase Technologies (Theralase Technologies Stock… [Read More]
Paradigm Capital analyst Daniel Rosenberg reiterated a “Buy” rating and C$1.50 target price on Sabio Holdings (Sabio Holdings Stock Quote,… [Read More]